Publication | Closed Access
66 HIGH SUSTAINED VIRAL RESPONSE AT 12- AND 24-WEEK FOLLOW-UP OF MK-5172 WITH PEGYLATED INTERFERON alfa-2b AND RIBAVIRIN (PR) IN HCV GENOTYPE 1 TREATMENT-NAIVE NON-CIRRHOTIC PATIENTS
11
Citations
0
References
2013
Year
Treatment-naive Non-cirrhotic PatientsViral PersistenceHepatologyHepatitis CViral HepatitisImmunologyHepatitis BHepatitisVirologyAntiviral TherapyChronic Viral InfectionAntiviral DrugMedicineViral Immunity
No additional data available for this publication yet. Check back later!